Home South Africa News South Africa aims to vaccinate one million by end of March

South Africa aims to vaccinate one million by end of March

J&J vaccine

SA is targeting an ambitious plan to vaccinate one million people against COVID-19 by the end of March after a late start to its inoculation campaign, the country’s health minister said Thursday.

So far around 32,000 healthcare workers have received vaccinations developed by US pharma giant Johnson & Johnson since 17 February, when the rollout began with the first batch of 80,000 doses.

The country, which was slow to join in the global jostle for vaccines, hopes to take delivery of another 500,000 doses from Johnson & Johnson in the coming days.

Thereafter, a consignment of 600,000 doses of the Pfizer/BioNTech coronavirus vaccine will follow.

“This will be able to get over 1.1 million people vaccinated between now and hopefully the end of March,” Health Minister Zweli Mkhize told lawmakers.

That will cover most of the country’s healthcare workers.

Africa’s hardest-hit nation by the pandemic suffered a setback after it decided against administering one million doses of the Oxford/AstraZeneca formula it received on 1 February, citing concerns over whether it protected against a widespread virus variant that emerged in the country.

Most of the large supplies of vaccines are expected to start flowing in from April to June, the minister said, noting the government was banking on bilateral negotiations to fill its deficit of doses.

On Wednesday, the government announced plans to allocate $688 million for vaccines.

South Africa, the continent’s most industrialized economy, aims to inoculate around 40 million people – 67% of the population – by the end of 2021.

It has already committed to deals for nine million doses of the Johnson & Johnson vaccine, 12 million doses from the Covax facility, and 20 million from Pfizer.

Mkhize said “a lot of work” was being done to acquire Russia’s Sputnik vaccine and Sinopharm from China.

Discussions are also ongoing for the purchase of jabs from US biotech firm Moderna, which said Wednesday it was ready to start test its new vaccine candidate aimed at the coronavirus variant identified in South Africa.

South Africa has recorded more than 1.5 million virus cases of which nearly 50,000 have been fatal.

-EWN

In other news – Master KG shows off his bank balance, Mzansi reacts

It is without a doubt that Master KG is swimming in cash following his successful Jerusalema tour and his successful music career in general.

Master KG

The muso is also about to be two times richer as he will be getting what’s due to him as his record label will be gunning for all those recording companies who used his song to profit from it. The wealthy producer is responsible for the world phenomenon that is the Jerusalem Challenge. Learn More